Breast Cancer: Our Clinical Trials

You may be offered the opportunity to take part in a clinical trial at some point during your treatment. Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies that are not yet readily available. Clinical trials may also be used to compare diagnostic tests, prevention strategies, or other aspects of care for cancer patients. Learn more about clinical trials.

Below is a listing of breast cancer clinical trials that are currently enrolling patients at Memorial Sloan Kettering Cancer Center.

Showing 51 - 61 of 61 trials
Title Investigatorsort icon
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142]
Dang, Chau, MD
A Phase IA/IB Study of RO5509554 Alone and with Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-086]
D'Angelo, Sandra, MD
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat, MD, PhD
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Subjects with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005]
Chandarlapaty, Sarat, MD, PhD
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie, PhD
A Study of Non-Hormonal Vaginal Moisturizer in Hormone Receptor-Positive Postmenopausal Cancer Survivors
[Protocol 12-232]
Carter, Jeanne, PhD
A Phase I/II Study of Nivolumab Alone and with Ipilimumab in Patients with Advanced or Metastatic Solid Tumors
Relapsed/Refractory
[Protocol 13-187]
Callahan, Margaret, MD, PhD
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
[Protocol 10-071]
Blinder, Victoria, MD
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine, MD, PhD
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079]
Ahles, Tim, PhD
Cognition in Older Breast Cancer Survivors: Influence of Treatment, Genetics, and Smoking History
[Protocol 14-071]
Ahles, Tim, PhD